World  /  Published 20.06.22

Parents face jab dilemma

It’s a moment many parents have anxiously awaited for months: Children younger than five years are now eligible for vaccination against the coronavirus, among the last Americans to qualify. Wit...
By Apoorva Mandavilli

Business  /  Published 04.05.22

Pfizer drug centre opens in Chennai

US pharmaceutical company Pfizer has set up its global drug development centre at the Indian Institute of Technology-Madras Research Park here, at an outlay of over Rs 150 crore. The centre, which em...
By Our Bureau, PTI in Chennai

World  /  Published 25.04.22

Mix-and-match approach to Covid-19

Giving a different vaccine as the third dose than was received for the first two shots leads to better performance compared to using the booster of same preventive, according to a study published in T...
By Our Bureau, PTI in Washington

Science Tech  /  Published 07.03.22

Battle of Memories

As people across the world grapple with the prospect of living with the coronavirus for the foreseeable future, one question looms large: how soon before they need yet another shot? Not for many mont...
By Apoorva Mandavilli

India  /  Published 27.01.22

Omicron booster for better immunity: Study

Research by Indian scientists has suggested that people infected with omicron after full immunisation with the AstraZeneca or Pfizer-BioNTech Covid-19 vaccines have significant immune responses that p...
By GS Mudur in New Delhi


World  /  Published 22.01.22

Boosters key to Covid fight

Booster shots of the Pfizer-BioNTech and Moderna vaccines aren’t just preventing infections with the contagious Omicron variant —  they’re also keeping infected Americans from e...
By Apoorva Mandavilli in New York

India  /  Published 21.01.22

Sputnik V stronger than Pfizer

The levels of Omicron-neutralising antibodies of people vaccinated with two doses of Russia's Sputnik V vaccine did not decline as much as of those who had Pfizer shots, according to a small study...
By Our Bureau, PTI in Moscow

Business  /  Published 18.01.22

Unilever to pursue GSK arm

Consumer goods giant Unilever on Monday indicated that it would continue to chase the consumer healthcare business of GlaxoSmithKline (GSK) plc, despite the latter rejecting its “unsolicited&rdq...
By Our Special Correspondent in Mumbai

World  /  Published 23.12.21

Second Covid pill cleared by US

The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high risk adults amid a winter surge of cases driven by the highly infectious Omicron variant. The decision...
By Our Bureau, Agencies in Washington

World  /  Published 21.12.21

Jabs ‘won’t stop omicron’

A growing body of preliminary research suggests the Covid vaccines used in most of the world offer almost no defence against becoming infected by the highly contagious omicron variant. All vaccines s...
By Stephanie Nolen in New York


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.